BRO Brown & Brown Inc

$BRO Can Brown & Brown get organic growth back above 1.2% after nine months at 0.3%, with its wholesale and programs arm still shrinking organically? 🏢 Brown & Brown, a Florida insurance broker worth about $22.71B at $67.87 a share at 11:01 ET on October 27, 2026, grew Q3 2026 revenue 7.4% to $1.725B, but organic growth slowed to 1.2% from 3.5% a year earlier 📉 Its Specialty Distribution segment's revenue rose 8.5% to $739M, but its organic revenue fell 0.8% against a 4.6% gain a year ago, and the 10-Q names falling catastrophe property rates as one drag 📈 On the other side, about $29M of last year's quarter was one-off interest on cash raised for the Accession deal, and Specialty Distribution's adjusted EBITDAC still rose 7.0% to $320M 📅 Next: Q4 2026 results, no date given yet; watch Specialty Distribution organic growth Source: Brown & Brown 8-K + 10-Q, Oct 26

$BRO Brown & Brown Q3 revenue was 1.725 billion dollars, up 7.4% year over year, but organic growth was only 1.2%. Adjusted EPS was 1.07 dollars, up from 1.05, just under the 1.08 consensus, and GAAP EPS actually fell to 0.67 from 0.68. Adjusted EBITDAC margin compressed to 34.6% from 36.6%. Most of the growth here is still coming from acquisitions, not the underlying book.

$BRO Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $1.07 up 1.90% YoY • Reported revenue of $1.7B up 9.68% YoY

$BRO Brown & Brown reports Monday after the close. Zacks consensus is 1.08 dollars a share on 1.76 billion dollars in revenue, up 2.9% and 9.8% from a year ago. Estimates have actually drifted a bit lower in the last 30 days, down 0.9%, even with acquisitions and new business still doing most of the growth work. Expenses from all that deal activity are the offset to watch.

Brown & Brown shares are expected to move approximately 1.8% when the insurance brokerage reports earnings on October 26 after market close, according to Bloomberg options data. However, the stock’s actual post-earnings move exceeded options-implied expectations in six of the last eight reports, suggesting the potential for greater-than-expected volatility. Recent reactions have been particularly sharp. In July, shares fell 11.5% in 2025 against an implied move of 4.3%, while in October 2025 they declined 6.3% versus just 1.6% expected. In April 2025, shares dropped 7.9% against an implied 4.3% move. More recently, the stock fell 7.4% in January despite options pricing in a 2.8% move, while July saw a 6.2% change versus 5.2% implied. These results highlight a pattern of downside surprises and volatility that has frequently exceeded market expectations, making the upcoming earnings release a potential catalyst for significant price movement. $BRO